Retour
Nykode Therapeutics ASA (VACBF) Gagner
Graphique du cours de l'action VACBF
VACBF Gagner
Nykode Therapeutics ASA
$0.38
0%
$0
À la fermeture : Mar 24, 16:00:00 GMT-4
$0.38
0%
$0
Post-Marché: Mar 24, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$0.38
Prix d'ouverture
$0.31
Plage de la journée
$0.31 - $0.38
Plage de 52 semaines
$0.1557 - $0.38
Volume
10.0K
Volume moyen
166
Rendement en dividend
--
BPA (TTM)
-0.03
Capitalisation boursière
$124.0M
Qu’est-ce que NYKODE THERAPEUTICS ASA ?
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 59 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.